The strongest part of this AP story was the quantification of worrisome side effects in patients who took these experimental drugs. But the article fell short in other areas, failing to go into detail about costs and giving an exaggerated estimate of benefits. We’d give a slight edge to competing coverage from The New York Times.
This New York Times story did a thorough job explaining the benefits and shortcomings of a series of trials looking into a class of cholesterol drugs. We especially liked how the piece addressed limitations and costs. More informative than the Associated Press coverage of the same studies.
This otherwise well-reported story is thrown off course by a misleading anecdote at the end. The story should have pushed back against a patient’s unfounded prognostications, or better yet, left them out of the coverage entirely.
This is an interesting, readable account of a new study on a hot topic. But identifying concussions with this new test isn’t quite as simple as the story suggests.
Our reviewers didn’t want to seem heartless toward a story that profiles volunteers doing wonderful work. But they couldn’t find much useful information for someone who might actually need the services described in this story.
This story notes that vegetarians had a 22% lower risk of colorectal cancer compared with non-vegetarians. But that 22% difference translates to only 1.4 fewer cases for every 10,000 people in the study. We think it’s helpful for readers to know that.
This story is about the development of a portable prototype device that delivers electrical stimulation to people with Parkinson’s disease. Readers needed more information to understand whether the benefits provided are meaningful.
The family-centered or “gentle” cesarean is an interesting concept and newsworthy for its innovation. This engaging NPR piece conveys much of what readers would want to know, but leans a bit too heavily on the opinions of advocates for our liking.
How much is “enough” when it comes to exercise, and is more always better? This NPR story tackles those difficult questions through coverage of a new exercise trial.